Safety and feasibility study of using polyphosphate (PolyP) in alveolar cleft repair: a pilot study

Abstract Background Bone grafting is an important surgical procedure to reconstruct alveolar bone defects in patients with cleft lip and palate. Polyphosphate (PolyP) is a physiological polymer present in the blood, primarily in platelets. PolyP plays a role as a phosphate source in bone calcium pho...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Salem A. Alkaabi, Diandra Sabrina Natsir Kalla, Ghamdan A. Alsabri, Abul Fauzi, Nova Jansen, Andi Tajrin, Rifaat Nurrahma, Werner Müller, Heinz C. Schröder, Wang Xiaohong, Tymour Forouzanfar, Marco N. Helder, Muhammad Ruslin
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/ba58acd7b3f14ca689a85b113bd40cc2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ba58acd7b3f14ca689a85b113bd40cc2
record_format dspace
spelling oai:doaj.org-article:ba58acd7b3f14ca689a85b113bd40cc22021-11-14T12:12:40ZSafety and feasibility study of using polyphosphate (PolyP) in alveolar cleft repair: a pilot study10.1186/s40814-021-00939-42055-5784https://doaj.org/article/ba58acd7b3f14ca689a85b113bd40cc22021-11-01T00:00:00Zhttps://doi.org/10.1186/s40814-021-00939-4https://doaj.org/toc/2055-5784Abstract Background Bone grafting is an important surgical procedure to reconstruct alveolar bone defects in patients with cleft lip and palate. Polyphosphate (PolyP) is a physiological polymer present in the blood, primarily in platelets. PolyP plays a role as a phosphate source in bone calcium phosphate deposition. Moreover, the cleavage of high-energy bonds to release phosphates provides local energy necessary for regenerative processes. In this study, polyP is complexed with calcium to form Calcium polyP microparticles (Ca-polyP MPs), which were shown to have osteoinductive properties in preclinical studies. The aim of this study was to evaluate the feasibility, safety, and osteoinductivity of Ca-polyP MPs, alone or in combination with BCP, in a first-in-human clinical trial. Methods This single-blinded, parallel, prospective clinical pilot study enrolled eight adolescent patients (mean age 18.1: range 13–34 years) with residual alveolar bone cleft. Randomization in two groups (four receiving Ca-polyP MPs only, four a combination of Ca-polyP MPs and biphasic calcium phosphate (BCP)) was performed. Patient follow-up was 6 months. Outcome parameters included safety parameters and close monitoring of possible adverse effects using radiographic imaging, regular blood tests, and physical examinations. Osteoinductivity evaluation using histomorphometric analysis of biopsies was not possible due to COVID restrictions. Results Due to surgical and feasibility reasons, eventually, only 2 patients received Ca-polyP MPs, and the others the combination graft. All patients were assessed up to day 90. Four out of eight were able to continue with the final assessment day (day 180). Three out of eight were unable to reach the hospital due to COVID-19 restrictions. One patient decided not to continue with the study. None of the patients showed any allergic reactions or any remarkable local or systematic side effects. Radiographically, patients receiving Ca-polyP MPs only were scored grade IV Bergland scale, while patients who got the BCP/Ca-polyP MPs combination had scores ranging from I to III. Conclusions Our results indicate that Ca-polyP MPs and the BCP/Ca-polyP MPs combination appear to be safe graft materials; however, in the current setting, Ca-polyP MPs alone may not be a sufficiently stable defect-filling scaffold to be used in alveolar cleft repair. Trial registration Indonesian Trial Registry under number INA-EW74C1N by the ethical committee of Faculty of Medicine, Hasanuddin University, Makassar, Indonesia with code number 1063/UN4.6.4.5.31/PP36/2019 .Salem A. AlkaabiDiandra Sabrina Natsir KallaGhamdan A. AlsabriAbul FauziNova JansenAndi TajrinRifaat NurrahmaWerner MüllerHeinz C. SchröderWang XiaohongTymour ForouzanfarMarco N. HelderMuhammad RuslinBMCarticlePolyphosphateAlveolar bone graftingBone regenerationRegenerative medicineMedicine (General)R5-920ENPilot and Feasibility Studies, Vol 7, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Polyphosphate
Alveolar bone grafting
Bone regeneration
Regenerative medicine
Medicine (General)
R5-920
spellingShingle Polyphosphate
Alveolar bone grafting
Bone regeneration
Regenerative medicine
Medicine (General)
R5-920
Salem A. Alkaabi
Diandra Sabrina Natsir Kalla
Ghamdan A. Alsabri
Abul Fauzi
Nova Jansen
Andi Tajrin
Rifaat Nurrahma
Werner Müller
Heinz C. Schröder
Wang Xiaohong
Tymour Forouzanfar
Marco N. Helder
Muhammad Ruslin
Safety and feasibility study of using polyphosphate (PolyP) in alveolar cleft repair: a pilot study
description Abstract Background Bone grafting is an important surgical procedure to reconstruct alveolar bone defects in patients with cleft lip and palate. Polyphosphate (PolyP) is a physiological polymer present in the blood, primarily in platelets. PolyP plays a role as a phosphate source in bone calcium phosphate deposition. Moreover, the cleavage of high-energy bonds to release phosphates provides local energy necessary for regenerative processes. In this study, polyP is complexed with calcium to form Calcium polyP microparticles (Ca-polyP MPs), which were shown to have osteoinductive properties in preclinical studies. The aim of this study was to evaluate the feasibility, safety, and osteoinductivity of Ca-polyP MPs, alone or in combination with BCP, in a first-in-human clinical trial. Methods This single-blinded, parallel, prospective clinical pilot study enrolled eight adolescent patients (mean age 18.1: range 13–34 years) with residual alveolar bone cleft. Randomization in two groups (four receiving Ca-polyP MPs only, four a combination of Ca-polyP MPs and biphasic calcium phosphate (BCP)) was performed. Patient follow-up was 6 months. Outcome parameters included safety parameters and close monitoring of possible adverse effects using radiographic imaging, regular blood tests, and physical examinations. Osteoinductivity evaluation using histomorphometric analysis of biopsies was not possible due to COVID restrictions. Results Due to surgical and feasibility reasons, eventually, only 2 patients received Ca-polyP MPs, and the others the combination graft. All patients were assessed up to day 90. Four out of eight were able to continue with the final assessment day (day 180). Three out of eight were unable to reach the hospital due to COVID-19 restrictions. One patient decided not to continue with the study. None of the patients showed any allergic reactions or any remarkable local or systematic side effects. Radiographically, patients receiving Ca-polyP MPs only were scored grade IV Bergland scale, while patients who got the BCP/Ca-polyP MPs combination had scores ranging from I to III. Conclusions Our results indicate that Ca-polyP MPs and the BCP/Ca-polyP MPs combination appear to be safe graft materials; however, in the current setting, Ca-polyP MPs alone may not be a sufficiently stable defect-filling scaffold to be used in alveolar cleft repair. Trial registration Indonesian Trial Registry under number INA-EW74C1N by the ethical committee of Faculty of Medicine, Hasanuddin University, Makassar, Indonesia with code number 1063/UN4.6.4.5.31/PP36/2019 .
format article
author Salem A. Alkaabi
Diandra Sabrina Natsir Kalla
Ghamdan A. Alsabri
Abul Fauzi
Nova Jansen
Andi Tajrin
Rifaat Nurrahma
Werner Müller
Heinz C. Schröder
Wang Xiaohong
Tymour Forouzanfar
Marco N. Helder
Muhammad Ruslin
author_facet Salem A. Alkaabi
Diandra Sabrina Natsir Kalla
Ghamdan A. Alsabri
Abul Fauzi
Nova Jansen
Andi Tajrin
Rifaat Nurrahma
Werner Müller
Heinz C. Schröder
Wang Xiaohong
Tymour Forouzanfar
Marco N. Helder
Muhammad Ruslin
author_sort Salem A. Alkaabi
title Safety and feasibility study of using polyphosphate (PolyP) in alveolar cleft repair: a pilot study
title_short Safety and feasibility study of using polyphosphate (PolyP) in alveolar cleft repair: a pilot study
title_full Safety and feasibility study of using polyphosphate (PolyP) in alveolar cleft repair: a pilot study
title_fullStr Safety and feasibility study of using polyphosphate (PolyP) in alveolar cleft repair: a pilot study
title_full_unstemmed Safety and feasibility study of using polyphosphate (PolyP) in alveolar cleft repair: a pilot study
title_sort safety and feasibility study of using polyphosphate (polyp) in alveolar cleft repair: a pilot study
publisher BMC
publishDate 2021
url https://doaj.org/article/ba58acd7b3f14ca689a85b113bd40cc2
work_keys_str_mv AT salemaalkaabi safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT diandrasabrinanatsirkalla safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT ghamdanaalsabri safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT abulfauzi safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT novajansen safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT anditajrin safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT rifaatnurrahma safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT wernermuller safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT heinzcschroder safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT wangxiaohong safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT tymourforouzanfar safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT marconhelder safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
AT muhammadruslin safetyandfeasibilitystudyofusingpolyphosphatepolypinalveolarcleftrepairapilotstudy
_version_ 1718429369729286144